ImmuneWatch

ImmuneWatch’s core mission is to crack one of the longest running challenges in systems immunology: predicting T-cell specificity with machine learning.

This journey started at the University of Antwerp and Antwerp University Hospital in Belgium when immunologists teamed up with biodata scientists within the AUDACIS consortium. The team pioneered the first work on using machine learning for TCR-epitope specificity predictions. Meanwhile, this collaboration led to more than 30 publications in the field of computational immunology.

Based on this success, ImmuneWatch was founded as a spin-off company and has since then significantly improved the technology, establishing themselves as world leaders in the field of TCR-epitope predictions.